arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Glaukos Corporation

GKOS Health Care Medical/Dental Instruments
$177.60
▲ +0.1% Today
as of Sep 4, 16:49 ET
Last 30 days +17.27% Jul 28 → Sep 04
$148.27 $159.36 $170.44 $181.52 $192.61 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$177.80
High
$181.27
Low
$175.13
Volume
$572,520
Avg Vol
$912,165
Mkt Cap
$10.1B
P/E (TTM)
—
Beta
—
52w High
$191.62
52w Low
$73.16
Div Yield
—
Shares Out
$59M

Recent Press Releases & News last 60 days · 25 items

Sep 2 · 08:05 MT Newswires
Glaukos Insider Sold Shares Worth $2,483,104, According to a Recent SEC Filing
Aug 28 · 15:30 Zacks
Glaukos (GKOS) Up 8% Since Last Earnings Report: Can It Continue?
Aug 20 · 15:54 Zacks
GKOS Stock Surges 67% Year to Date: What's Driving the Rally?
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$73
$192
88% of range
Avg surprise (last 2)
+20.5%
Avg reaction (last 1)
+0.4%
100% positive
Latest IV / EM
44%
EM ±6.8% · $180 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.00$-0.80$-0.61$-0.42$-0.22 Actual $-0.72Actual $-0.68Actual $-0.63Actual $-0.82Actual $-1.00Actual $-0.39Actual $-0.22Est $-0.33Actual $-0.24Est $-0.26Actual $-0.28Actual $-0.34Actual $-0.31 MarJunSepMarJunSepMar/2025Jun/2025SepMarJun
Revenue vs Net Income Revenue Net income
$-21M$33M$87M$141M$195M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.31 — — — — financials
Tue Mar 31, 2026Mar 2026 $-0.34 — — — — financials
Tue Sep 30, 2025Sep 2025 $-0.28 — — — — financials
Wed Jul 30, 2025Jun/2025 $-0.24 $-0.26 +7.7% — — earnings
Wed Apr 30, 2025Mar/2025 $-0.22 $-0.33 +33.3% — +0.4% earnings
Mon Sep 30, 2024Sep 2024 $-0.39 — — — — financials
Sun Jun 30, 2024Jun 2024 $-1.00 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.82 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.63 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.68 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.72 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$186M$151M—$134M$124M$107M—$97M
Cost of revenue$34M$33M—$29M$27M$24M—$23M
Gross profit$152M$117M—$105M$97M$82M—$74M
Operating income$-17M$-20M—$-16M$-23M$-21M—$-25M
Net income$-18M$-20M—$-16M$-20M$-18M—$-21M
EPS (diluted)$-0.31$-0.34—$-0.28$-0.34$-0.32—$-0.39

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$114M$104M$91M$98M$101M$114M$170M$100M
Inventory$59M$62M$64M$64M$65M$59M$58M$60M
Total current assets$516M$486M$475M$455M$436M$445M$450M$397M
Total assets$921M$893M$893M$999M$987M$966M$975M$927M
Long-term debt————————
Total liabilities$238M$222M$237M$230M$222M$202M$208M$258M
Total equity$682M$671M$656M$770M$765M$764M$767M$669M

Implied volatility — last 90 days

35%55%75%95%116% Jun 07 — IV 80% · EM ±11.0%Jun 08 — IV 82% · EM ±10.8%Jun 09 — IV 71% · EM ±8.9%Jun 10 — IV 68% · EM ±8.0%Jun 11 — IV 63% · EM ±6.9%Jun 12 — IV 60% · EM ±6.2%Jun 15 — IV 68% · EM ±4.9%Jun 16 — IV 77% · EM ±4.5%Jun 17 — IV 116% · EM ±4.8%Jun 19 — IV 58% · EM ±12.8%Jun 22 — IV 53% · EM ±11.2%Jun 23 — IV 50% · EM ±10.2%Jun 24 — IV 53% · EM ±10.7%Jun 25 — IV 52% · EM ±10.2%Jun 26 — IV 50% · EM ±9.7%Jun 29 — IV 51% · EM ±9.0%Jun 30 — IV 54% · EM ±9.3%Jul 01 — IV 55% · EM ±9.2%Jul 02 — IV 50% · EM ±8.1%Jul 03 — IV 52% · EM ±8.1%Jul 06 — IV 57% · EM ±7.9%Jul 07 — IV 57% · EM ±7.5%Jul 08 — IV 53% · EM ±6.7%Jul 09 — IV 55% · EM ±6.5%Jul 10 — IV 57% · EM ±6.3%Jul 13 — IV 65% · EM ±5.5%Jul 14 — IV 77% · EM ±5.6%Jul 15 — IV 68% · EM ±4.0%Jul 16 — IV 71% · EM ±3.0%Jul 20 — IV 65% · EM ±15.2%Jul 21 — IV 67% · EM ±15.6%Jul 22 — IV 67% · EM ±15.2%Jul 23 — IV 68% · EM ±15.3%Jul 24 — IV 69% · EM ±15.2%Jul 27 — IV 82% · EM ±17.2%Jul 28 — IV 105% · EM ±21.5%Jul 29 — IV 88% · EM ±17.6%Jul 30 — IV 53% · EM ±10.4%Jul 31 — IV 50% · EM ±9.6%Aug 03 — IV 54% · EM ±9.5%Aug 04 — IV 53% · EM ±9.1%Aug 05 — IV 51% · EM ±8.5%Aug 06 — IV 45% · EM ±7.3%Aug 07 — IV 42% · EM ±6.5%Aug 10 — IV 44% · EM ±6.1%Aug 11 — IV 38% · EM ±5.1%Aug 12 — IV 41% · EM ±5.1%Aug 13 — IV 40% · EM ±4.8%Aug 14 — IV 35% · EM ±3.9%Aug 17 — IV 42% · EM ±3.5%Aug 18 — IV 46% · EM ±3.3%Aug 19 — IV 49% · EM ±2.9%Aug 20 — IV 62% · EM ±2.6%Aug 24 — IV 44% · EM ±9.1%Aug 25 — IV 44% · EM ±9.0%Aug 26 — IV 42% · EM ±8.5%Aug 27 — IV 45% · EM ±8.9%Aug 28 — IV 43% · EM ±8.3%Aug 31 — IV 42% · EM ±7.5%Sep 01 — IV 45% · EM ±7.7%Sep 02 — IV 45% · EM ±7.5%Sep 03 — IV 43% · EM ±6.9%Sep 04 — IV 44% · EM ±6.8%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in